Fulvestrant in the treatment of hormone receptor-positive advanced breast cancer - A cost-effective addition to the treatment sequence.

被引：0
|
作者：
Cameron, D. A.
Camidge, D. R.
Gait, C.
Hirsch, M.
机构：
[1] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Mapi Values, Cheshire, England
[3] AstraZeneca, Macclesfield, Cheshire, England
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S231 / S232
页数：2
相关论文
共 50 条
  • [1] Fulvestrant: Expanding the endocrine treatment options for patients with hormone receptor-positive advanced breast cancer
    Chia, Stephen
    Gradishar, William
    BREAST, 2008, 17 : S16 - S21
  • [2] FULVESTRANT ('FASLODEX'): A NEW OPTION FOR THE TREATMENT OF HORMONE RECEPTOR-POSITIVE, ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN
    Kleeberg, Ulrich R.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3537 - 3537
  • [3] Cost-effectiveness analysis of fulvestrant versus anastrozole as first-line treatment for hormone receptor-positive advanced breast cancer
    Ding, H.
    Fang, L.
    Xin, W.
    Tong, Y.
    Zhou, Q.
    Huang, P.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)
  • [4] Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer
    Sarah Sammons
    Noah S. Kornblum
    Kimberly L. Blackwell
    Targeted Oncology, 2019, 14 : 1 - 12
  • [5] Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer
    Sammons, Sarah
    Kornblum, Noah S.
    Blackwell, Kimberly L.
    TARGETED ONCOLOGY, 2019, 14 (01) : 1 - 12
  • [6] Fulvestrant in management of hormone receptor-positive metastatic breast cancer
    Shafaee, Maryam Nemati
    Ellis, Matthew James
    FUTURE ONCOLOGY, 2018, 14 (18) : 1789 - 1800
  • [7] Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib
    Morita, Midori
    Ooe, Asako
    Ishii, Wataru
    Watanabe, Akira
    Matsui, Chise
    Okuyama, Yuka
    Kitano, Sae
    Kato, Chikage
    Onishi, Mie
    Sakaguchi, Koichi
    Naoi, Yasuto
    ANTICANCER RESEARCH, 2023, 43 (06) : 2783 - 2789
  • [8] Everolimus in the treatment of hormone receptor-positive breast cancer
    Chavez-MacGregor, Mariana
    Gonzalez-Angulo, Ana Maria
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (12) : 1835 - 1843
  • [9] Fulvestrant in the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: A review
    Li, Junjie
    Wang, Zhonghua
    Shao, Zhimin
    CANCER MEDICINE, 2019, 8 (05): : 1943 - 1957
  • [10] Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment
    Dobovisek, Luka
    Krstanovic, Fran
    Borstnar, Simona
    Debeljak, Natasa
    CANCERS, 2020, 12 (03)
12345